Opocrin S.p.A. becomes a supplier of active pharmaceutical ingredients of animal origin
Opocrin S.p.A. is classified by the FDA and by the Canadian authorities as an acceptable supplier for active pharmaceutical ingredients of animal origin.
Previous PostStudy, development and creation of the production process for a polysaccharide of vegetable origin (Arabinogalactan)
Next PostOpocrin S.p.A. obtains CE certification for its medical products containing collagen
